Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas.

Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S, Chernov M, Kawamata T, Muragaki Y.

J Neurooncol. 2019 Sep;144(3):519-528. doi: 10.1007/s11060-019-03250-8. Epub 2019 Jul 30.

PMID:
31363908
2.

To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatment.

Paľa A, Coburger J, Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Scheuerle A, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Schmitz B, Unterberg AW.

J Neurosurg. 2019 Jul 19:1-8. doi: 10.3171/2019.4.JNS183395. [Epub ahead of print]

PMID:
31323633
3.

Evaluation of DNA ploidy with intraoperative flow cytometry may predict long-term survival of patients with supratentorial low-grade gliomas: Analysis of 102 cases.

Suzuki A, Maruyama T, Nitta M, Komori T, Ikuta S, Chernov M, Tamura M, Kawamata T, Muragaki Y.

Clin Neurol Neurosurg. 2018 May;168:46-53. doi: 10.1016/j.clineuro.2018.02.027. Epub 2018 Feb 21.

PMID:
29522936
4.

Huge heterogeneity in survival in a subset of adult patients with resected, wild-type isocitrate dehydrogenase status, WHO grade II astrocytomas.

Poulen G, Gozé C, Rigau V, Duffau H.

J Neurosurg. 2018 Apr 20:1-10. doi: 10.3171/2017.10.JNS171825. [Epub ahead of print]

PMID:
29676695
5.

Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Nahed BV, Redjal N, Brat DJ, Chi AS, Oh K, Batchelor TT, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):609-30. doi: 10.1007/s11060-015-1910-2. Epub 2015 Nov 3. Review.

PMID:
26530264
6.

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.

Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K, Iseki H, Tamura M, Saito T, Okamoto S, Chernov M, Hayashi M, Okada Y.

Neurosurg Focus. 2015 Jan;38(1):E7. doi: 10.3171/2014.10.FOCUS14651.

PMID:
25599276
7.

Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.

Duffau H.

Acta Neurochir (Wien). 2016 Jan;158(1):51-8. doi: 10.1007/s00701-015-2621-3. Epub 2015 Nov 3.

PMID:
26530708
8.

Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.

Yordanova YN, Moritz-Gasser S, Duffau H.

J Neurosurg. 2011 Aug;115(2):232-9. doi: 10.3171/2011.3.JNS101333. Epub 2011 May 6.

PMID:
21548750
9.

The evolving molecular genetics of low-grade glioma.

Venneti S, Huse JT.

Adv Anat Pathol. 2015 Mar;22(2):94-101. doi: 10.1097/PAP.0000000000000049. Review. Erratum in: Adv Anat Pathol. 2015 May;22(3):226.

10.

Free survival time of recurrence and malignant transformation and associated factors in patients with supratentorial low-grade gliomas.

Sakarunchai I, Sangthong R, Phuenpathom N, Phukaoloun M.

J Med Assoc Thai. 2013 Dec;96(12):1542-9.

PMID:
24511718
11.

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D.

Neuro Oncol. 2013 Jun;15(6):682-90. doi: 10.1093/neuonc/not006. Epub 2013 Feb 14.

12.

Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.

Compes P, Tabouret E, Etcheverry A, Colin C, Appay R, Cordier N, Mosser J, Chinot O, Delingette H, Girard N, Dufour H, Metellus P, Figarella-Branger D.

J Neurooncol. 2019 May;142(3):511-520. doi: 10.1007/s11060-019-03122-1. Epub 2019 Feb 11. Erratum in: J Neurooncol. 2019 Mar 11;:.

PMID:
30756272
13.

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, Shonka N, Gilbert MR, Sawaya R, Prabhu SS, Weinberg J, Lang FF, Aldape KD, Sulman EP, Rao G, McCutcheon IE, Cahill DP.

Neuro Oncol. 2014 Jan;16(1):81-91. doi: 10.1093/neuonc/not159. Epub 2013 Dec 4.

14.

Low-grade gliomas.

Stieber VW.

Curr Treat Options Oncol. 2001 Dec;2(6):495-506. Review.

PMID:
12057095
15.

Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.

Sanai N, Polley MY, Berger MS.

J Neurosurg. 2010 Jan;112(1):1-9. doi: 10.3171/2009.6.JNS0952.

PMID:
19612970
16.

Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.

Huynh-Le MP, Walker AJ, Burger PC, Jallo GI, Cohen KJ, Wharam MD, Terezakis SA.

Childs Nerv Syst. 2016 Aug;32(8):1425-30. doi: 10.1007/s00381-016-3100-8. Epub 2016 May 14.

PMID:
27179530
17.

Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas.

Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):704-10.

PMID:
11597812
18.

Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.

Morshed RA, Han SJ, Hervey-Jumper SL, Pekmezci M, Troncon I, Chang SM, Butowski NA, Berger MS.

J Neurooncol. 2019 Jan;141(2):383-391. doi: 10.1007/s11060-018-03044-4. Epub 2018 Nov 29.

PMID:
30498891
19.

Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.

Bø HK, Solheim O, Kvistad KA, Berntsen EM, Torp SH, Skjulsvik AJ, Reinertsen I, Iversen DH, Unsgård G, Jakola AS.

J Neurosurg. 2019 Feb 1:1-12. doi: 10.3171/2018.10.JNS181290. [Epub ahead of print]

PMID:
30717057
20.

Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.

Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 Jan;112(1):10-7. doi: 10.3171/2008.10.JNS08608.

PMID:
19361270

Supplemental Content

Support Center